Exelixis Inc. Common Stock vs FormFactor Inc. FormFactor Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $60.73 (market cap $14.62B), while FormFactor Inc. FormFactor Inc. Common Stock trades at $141.39 (market cap $10.71B). The key difference: Exelixis Inc. Common Stock is the larger of the two by market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, FormFactor Inc. FormFactor Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and FormFactor Inc. FormFactor Inc. Common Stock for 0 Days on average.
| EXEL | FORM | |
|---|---|---|
Market Cap | $14.62B | $10.71B |
Volume | 2,684,957 | 1,680,425 |
Sector | Health | Technology |
52-Week High | $59.13 | $159.93 |
52-Week Low | $34.54 | $38.14 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.95B | $10.40B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →FormFactor, Inc. provides semiconductor test and measurement technologies used across the integrated circuit lifecycle, manufacturing probe cards and analytical probes through its Probe Cards segment and probe stations, thermal systems, and cryogenic systems through its Systems segment.
Read more on FORM →